Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
06/2011
06/01/2011CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/01/2011CN102083796A Trisubstituted 3,4-dihydro-1H-isoquinolin compound, process for its preparation, and its use
05/2011
05/31/2011US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011CA2555745C Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
05/31/2011CA2475764C New inhibitors of histone deacetylase
05/26/2011WO2011061318A1 Heterocylic compounds as antagonists of the orexin receptors
05/26/2011US20110124679 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
05/26/2011US20110124669 Modulators of Cellular Adhesion
05/26/2011US20110124625 Modulators of Cellular Adhesion
05/25/2011EP2325279A2 Electroluminescent iridium compounds
05/25/2011EP2323978A1 Amide compound
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
05/25/2011CN102070525A Tetrahydroisoquinoline derivatives and preparation method and application thereof
05/25/2011CN101142187B Ionic organic compound
05/24/2011US7947838 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
05/24/2011US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
05/24/2011US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011CA2499690C Diaryl ethers as opioid receptor antagonist
05/24/2011CA2491701C Fredericamycin derivatives as drugs for tumor treatment
05/24/2011CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
05/24/2011CA2393710C Caspase inhibitors and uses thereof
05/24/2011CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/19/2011WO2011059731A1 Alkynyl derivatives useful as dpp-1 inhibitors
05/19/2011WO2011057784A1 Compounds for pim kinase inhibition and for treating malignancy
05/19/2011WO2011038169A3 Oxalamide derivative as umami flavouring agent
05/19/2011US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof
05/19/2011CA2776829A1 Compounds for pim kinase inhibition and for treating malignancy
05/18/2011CN102060765A Tetrahydroisoquinoline derivative, preparation method and application thereof
05/18/2011CN102060764A Tetrahydroisoquinoline derivative, preparation method and application thereof
05/18/2011CN101490007B VR1 vanilloid receptor antagonists with a iononic substructure
05/17/2011US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss
05/17/2011US7943630 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/17/2011CA2514267C Malonamide derivatives as gamma-secretase inhibitors
05/12/2011WO2011056965A1 Method for extracting and purifying bisbenzylisoquinolines
05/12/2011WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof
05/12/2011US20110111959 Pollen tube stimulants from arabidopsis pistils
05/11/2011EP2318355A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
05/11/2011CN101177370B Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid
05/10/2011US7939666 Enzyme inhibitors
05/10/2011CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
05/05/2011WO2005060456A9 Method for treating adamts-5-associate disease
05/05/2011US20110105555 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
05/05/2011US20110105502 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
05/05/2011US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
05/05/2011US20110105329 Substituted Quinolinones Having Herbicidal Action
05/04/2011EP1852421B1 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof
05/04/2011EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
05/04/2011CN102040556A Optical isomers of indene quinazoline, preparation method and medicinal application thereof
05/03/2011US7935715 Compounds which modulate the CB2 receptor
04/2011
04/28/2011WO2011050199A1 Methods and compositions for panic disorders
04/28/2011WO2011049226A1 Metal complex, polymer, and element obtained using same
04/28/2011WO2011048607A1 Processes for the preparation of solifenacin or a salt thereof
04/28/2011WO2011014009A3 Novel di-substituted phenoxyacetyl-based compound or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for suppressing multiple drug resistance comprising same as an active ingredient
04/28/2011US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands
04/27/2011EP2313374A1 6-substituted isoquinolines and isoquinolinones
04/27/2011EP0850296B1 Color-safe bleach boosters, compositions and laundry methods employing same
04/27/2011CN102036964A Tetrahydroisoquinolines as antimalarial agents
04/27/2011CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof
04/26/2011US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/26/2011US7932266 Ester or amide derived from (3-sec-butyl-1-(thio)oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid; neurodegenerative diseases, cerebral and cardiac ischemias
04/26/2011US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds
04/26/2011CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
04/26/2011CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
04/21/2011WO2011046082A1 Oxime ether derivative or salt thereof, and agricultural/horticultural germicide
04/21/2011WO2011044637A1 Affinity ligands and methods for protein purification
04/21/2011US20110092476 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
04/20/2011EP2311810A1 Amidine derivative
04/20/2011EP2309860A1 Monocyclic cyanoenones and methods of use thereof
04/20/2011CN102026980A Isoquinolinone derivatives as NK3 antagonists
04/20/2011CN102026979A Process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative
04/20/2011CN102026961A Amide compound
04/19/2011US7928239 Anticarcinogenic agents
04/19/2011US7928209 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA
04/19/2011US7928137 Meta-benzamidine derivatives as serine protease inhibitors
04/19/2011US7928122 Modulators of cellular adhesion
04/19/2011CA2539853C Isoquinolinone potassium channel inhibitors
04/14/2011WO2011043480A1 Homocysteine synthase inhibitor
04/14/2011WO2011042145A1 Wnt pathway antagonists
04/13/2011EP2308846A2 Caspase inhibitors and uses thereof
04/13/2011EP2308845A2 Caspase inhibitors and uses thereof
04/13/2011EP2308844A2 Caspase inhibitors and uses thereof
04/13/2011EP2125744B1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
04/13/2011EP1931636B1 Isoquinolines as igf-1r inhibitors
04/13/2011CN1958568B A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application
04/13/2011CN1926109B Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
04/13/2011CN102015606A IRE-1a inhibitors
04/12/2011US7923446 Biaryl sulfonamides and methods for using same
04/12/2011CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
04/06/2011EP2306789A1 Phenyl-pyridine compounds
04/06/2011EP2306788A1 Iridium compounds and devices made therewith
04/06/2011EP2305260A1 Psychotropic agent and health food containing benzylisoquinoline derivative
04/06/2011EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels
04/06/2011EP2303846A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
04/06/2011EP2303845A2 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
04/06/2011EP2303015A2 Chemical compounds
04/06/2011CN102007102A Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
04/06/2011CN102007101A Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
04/06/2011CN102001997A Method for refining dauricine
04/05/2011US7919624 VR1 vanilloid receptor antagonists with a iononic substructure
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 119